Should Cathie wood invest in DNA stocks?

Ark Investment Management's Cathie Wood explains why, in spite of her confidence in Tesla Inc., she thinks DNA stocks are likely to "surprise" as the biggest growth engines in her portfolios. Wood also discusses when she might invest in so-called FANG stocks. She spoke exclusively to Erik Schatzker on Dec. 14 on Bloomberg's "Front Row."

Who is Cathie wood?

Cathie Wood has been adding shares of biotech company Ginkgo Bioworks ( DNA) to her exchange-traded funds (ETFs) in recent days. The buys are bringing attention to Ginkgo, which specializes in genetic engineering. However, Wood is still a controversial figure in investing, attracting both supporters and critics.

Is Cathie Wood getting enough of Ginkgo Bioworks?

Cathie Wood can’t seem to get enough of Ginkgo Bioworks (NYSE: DNA ). Running ARK Invest, Wood has acquired more than 250,000 shares of DNA stock. The Boston-based biotechnology company finished trading at $3.31 per share on Oct. 5.

Is Cathie wood buying these 3 growth stocks?

Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You? Cathie Wood recently added more than a million shares of a synthetic biology company called Ginkgo Bioworks to the Ark Innovation ETF. PagerDuty's automated tech-support platform is a hit with big enterprise customers from tech and non-tech industries.